🇺🇸 FDA
Patent

US 10981915

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

granted A61PA61P1/04A61P13/12

Quick answer

US patent 10981915 (Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors) held by Valo Early Discovery, Inc. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Valo Early Discovery, Inc.
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/04, A61P13/12, A61P19/02, A61P19/08